WTO/WHO – PRICING
June 1st, 2001
BY KEITH NUTHALLDIFFERENTIAL pricing in world pharmaceutical markets has been backed by a joint workshop involving the World Trade Organisation, the World Health Organisation, the Global Health Council and its national host, Norway.A report released from the meeting has born out a general consensus reached by participants that "differential pricing could, and should, play an important role in ensuring access to existing essential drugs at affordable prices, especially in poor countries, while allowing the patent system to continue to play its role of providing ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.